All Outputs (7)

Abstract P2-02-03: the collagen receptor Endo180: a metastatic plasma marker in breast cancer modulated by bisphosphonate treatment (2012)
Presentation / Conference Contribution
Sturge, J., Caley, M., Purshouse, K., Fonseca, A., Rodriguez-Teja, M., Kogianni, G., …Palmieri, C. (2012). Abstract P2-02-03: the collagen receptor Endo180: a metastatic plasma marker in breast cancer modulated by bisphosphonate treatment. Cancer Research, 72(24 suppl), https://doi.org/10.1158/0008-5472.sabcs12-p2-02-03

Sphingosine kinase-1 and the collagen-binding receptor Endo180 cooperate to mediate collagen remodelling by stromal fibroblasts (2010)
Presentation / Conference Contribution
Bruche, S., Caley, M., Pshezhetskiy, D., & Sturge, J. (2010). Sphingosine kinase-1 and the collagen-binding receptor Endo180 cooperate to mediate collagen remodelling by stromal fibroblasts. International Journal of Experimental Pathology, 91(6), A9

Macrophage-mediated breast cancer cell chemotaxis: the role of sphingosine kinase-1 activation (2010)
Presentation / Conference Contribution
Nunes, J., Sauer, L., Turner, J., Waxman, J., Sturge, J., & Pshezhetskiy, D. (2010). Macrophage-mediated breast cancer cell chemotaxis: the role of sphingosine kinase-1 activation. Breast Cancer Research, 12(S1), S6-S6. https://doi.org/10.1186/bcr2513

Collagen remodelling by osteoblast and prostate vancer vell interactions in metastatic bone lesions (2009)
Presentation / Conference Contribution
Sturge, J. (2009). Collagen remodelling by osteoblast and prostate vancer vell interactions in metastatic bone lesions.

A major clinical complication in patients with advanced prostate cancer is metastasis to bone where osteoblastic and/or osteoclastic activity results in a highly destructive tissue remodelling process.Recent in vivo studies have identified important... Read More about Collagen remodelling by osteoblast and prostate vancer vell interactions in metastatic bone lesions.

The role of endo180 in the development of metastatic prostate cancer bone lesions (2008)
Presentation / Conference Contribution
Kogianni, G., Elefteriou, K., Waxman, . J., Cobb, . J. P., & Sturge, J. (2008). The role of endo180 in the development of metastatic prostate cancer bone lesions. Anticancer research, 28(5C), 3354-3355

Endo180 expression by tumour cells with an invasive phenotype correlates with prostate cancer progression (2008)
Presentation / Conference Contribution
Kogianni, G., Walker, M., Waxman, J., & Sturge, J. (2008). Endo180 expression by tumour cells with an invasive phenotype correlates with prostate cancer progression. EJC Supplements, 6(9), 79. https://doi.org/10.1016/s1359-6349%2808%2971480-0

OC6. Endo180 function in metastatic prostate cancer bone lesions (2008)
Presentation / Conference Contribution
Kogianni, G., Eleftheriou, K., Waxman, J., Cobb, J. P., & Sturge, J. (2008). OC6. Endo180 function in metastatic prostate cancer bone lesions. Cancer Treatment Reviews, 34(Suppl 1), 51. https://doi.org/10.1016/j.ctrv.2008.03.032